209 related articles for article (PubMed ID: 31693393)
1. TRPV4 channel mediates adventitial fibroblast activation and adventitial remodeling in pulmonary hypertension.
Cussac LA; Cardouat G; Tiruchellvam Pillai N; Campagnac M; Robillard P; Montillaud A; Guibert C; Gailly P; Marthan R; Quignard JF; Savineau JP; Ducret T
Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L135-L146. PubMed ID: 31693393
[TBL] [Abstract][Full Text] [Related]
2. Effect of hypoxia on TRPV1 and TRPV4 channels in rat pulmonary arterial smooth muscle cells.
Parpaite T; Cardouat G; Mauroux M; Gillibert-Duplantier J; Robillard P; Quignard JF; Marthan R; Savineau JP; Ducret T
Pflugers Arch; 2016 Jan; 468(1):111-130. PubMed ID: 25799977
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of osmo-mechanosensitive TRPV4 channel facilitates chronic hypoxia-induced myogenic tone and pulmonary hypertension.
Yang XR; Lin AH; Hughes JM; Flavahan NA; Cao YN; Liedtke W; Sham JS
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L555-68. PubMed ID: 22207590
[TBL] [Abstract][Full Text] [Related]
4. Implication of the ryanodine receptor in TRPV4-induced calcium response in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic rats.
Dahan D; Ducret T; Quignard JF; Marthan R; Savineau JP; Estève E
Am J Physiol Lung Cell Mol Physiol; 2012 Nov; 303(9):L824-33. PubMed ID: 22962011
[TBL] [Abstract][Full Text] [Related]
5. Elk-1-mediated 15-lipoxygenase expression is required for hypoxia-induced pulmonary vascular adventitial fibroblast dynamics.
Li Y; Zhang L; Wang X; Chen M; Liu Y; Xing Y; Wang X; Gao S; Zhu D
Acta Physiol (Oxf); 2016 Dec; 218(4):276-289. PubMed ID: 27174674
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
Barman SA; Chen F; Su Y; Dimitropoulou C; Wang Y; Catravas JD; Han W; Orfi L; Szantai-Kis C; Keri G; Szabadkai I; Barabutis N; Rafikova O; Rafikov R; Black SM; Jonigk D; Giannis A; Asmis R; Stepp DW; Ramesh G; Fulton DJ
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1704-15. PubMed ID: 24947524
[TBL] [Abstract][Full Text] [Related]
7. Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension.
Li K; Li Y; Yu Y; Ding J; Huang H; Chu C; Hu L; Yu Y; Cao Y; Xu P; Fulton D; Chen F
BMC Pulm Med; 2021 Mar; 21(1):80. PubMed ID: 33673825
[TBL] [Abstract][Full Text] [Related]
8. Serotonin drives the activation of pulmonary artery adventitial fibroblasts and TGF-β1/Smad3-mediated fibrotic responses through 5-HT(2A) receptors.
Chen C; Han X; Fan F; Liu Y; Wang T; Wang J; Hu P; Ma A; Tian H
Mol Cell Biochem; 2014 Dec; 397(1-2):267-76. PubMed ID: 25185755
[TBL] [Abstract][Full Text] [Related]
9. miR-29a-3p attenuates hypoxic pulmonary hypertension by inhibiting pulmonary adventitial fibroblast activation.
Luo Y; Dong HY; Zhang B; Feng Z; Liu Y; Gao YQ; Dong MQ; Li ZC
Hypertension; 2015 Feb; 65(2):414-20. PubMed ID: 25421979
[TBL] [Abstract][Full Text] [Related]
10. Involvement of TRPV1 and TRPV4 channels in migration of rat pulmonary arterial smooth muscle cells.
Martin E; Dahan D; Cardouat G; Gillibert-Duplantier J; Marthan R; Savineau JP; Ducret T
Pflugers Arch; 2012 Sep; 464(3):261-72. PubMed ID: 22820913
[TBL] [Abstract][Full Text] [Related]
11. Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension.
Carlin CM; Celnik DF; Pak O; Wadsworth R; Peacock AJ; Welsh DJ
Am J Respir Cell Mol Biol; 2012 Aug; 47(2):140-8. PubMed ID: 22383583
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
13. TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension.
Xia Y; Fu Z; Hu J; Huang C; Paudel O; Cai S; Liedtke W; Sham JS
Am J Physiol Cell Physiol; 2013 Oct; 305(7):C704-15. PubMed ID: 23739180
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
Li M; Riddle S; Zhang H; D'Alessandro A; Flockton A; Serkova NJ; Hansen KC; Moldovan R; McKeon BA; Frid M; Kumar S; Li H; Liu H; Caánovas A; Medrano JF; Thomas MG; Iloska D; Plecitá-Hlavatá L; Ježek P; Pullamsetti S; Fini MA; El Kasmi KC; Zhang Q; Stenmark KR
Circulation; 2016 Oct; 134(15):1105-1121. PubMed ID: 27562971
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.
Penumatsa KC; Toksoz D; Warburton RR; Kharnaf M; Preston IR; Kapur NK; Khosla C; Hill NS; Fanburg BL
Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L752-L762. PubMed ID: 28775095
[TBL] [Abstract][Full Text] [Related]
16. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
17. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension.
Luo H; Liu B; Zhao L; He J; Li T; Zha L; Li X; Qi Q; Liu Y; Yu Z
J Am Soc Hypertens; 2017 Oct; 11(10):673-683.e3. PubMed ID: 28826890
[TBL] [Abstract][Full Text] [Related]
19. Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension.
Barman SA; Fulton D
Adv Exp Med Biol; 2017; 967():1-11. PubMed ID: 29047077
[TBL] [Abstract][Full Text] [Related]
20. SB-431542, a specific inhibitor of the TGF-β type I receptor inhibits hypoxia-induced proliferation of pulmonary artery adventitial fibroblasts.
Yuan W; Liu W; Cai H; Sun X; Yang D; Xu F; Jin C
Pharmazie; 2016 Feb; 71(2):94-100. PubMed ID: 27004374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
